Product Information
TIMOLOL MALEATE 0.5% EYE DROPS is a generic product labeled by Micro Labs Limited, priced at $1.0460 per ML under NDC 42571040421. Its NADAC has been published 78 times since Apr 9, 2025.
FDA first approved this application on May 26, 2023. Its Orange Book therapeutic-equivalence code is AT1.
Strength
5 mg/mL
Manufacturer
Micro Labs LimitedNDC
42571040421
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA217343FDA Approved
5/26/2023
TE Code
AT1
On Market Since
8/1/2023
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL MALEATE 0.5% EYE DROPS has been published 78 times since Apr 9, 2025, and over the history we have for it it has declined 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0460 per ML |
|---|---|
| All-time high | $1.1256 (Apr 16, 2025) |
| All-time low | $1.0406 (Jul 22, 2026) |
| 52-week high | $1.0969 |
| 52-week low | $1.0406 |
| Median price | $1.0799 |
| Average price | $1.0763 |
| Largest weekly change | -2.1% (Sep 17, 2025) |
| Weeks tracked | 78 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol Maleate Ophthalmic market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL MALEATE 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.5% EYE DROPS, manufactured by Micro Labs Limited, is $1.0460 per ML (NDC 42571040421), effective Sep 30, 2026.
How has the price of TIMOLOL MALEATE 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.5% EYE DROPS has declined 7.1%. It has been tracked across 78 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.5% EYE DROPS?
Since Apr 9, 2025, the NADAC for TIMOLOL MALEATE 0.5% EYE DROPS has ranged from a low of $1.0406 (Jul 22, 2026) to a high of $1.1256 (Apr 16, 2025), with a median of $1.0799 per ML.
Are there cheaper alternatives to TIMOLOL MALEATE 0.5% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.5% EYE DROPS, is $0.7197 per ML — about 31% below TIMOLOL MALEATE 0.5% EYE DROPS.
Who manufactures TIMOLOL MALEATE 0.5% EYE DROPS?
TIMOLOL MALEATE 0.5% EYE DROPS (NDC 42571040421) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.